The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Coradini Robert since 2010.
The trader's CIK number is 1474528.
At the time of the last reporting, Coradini Robert was the Director of Strata Skin Sciences, Inc.. (stock ticker symbol SSKN).
Also see all insider trading activities at Strata Skin Sciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | WGBS | 59,391 | $59,391 | 0 | $0 | 2,500 | $0 |
| 2010 | WGBS | 125,000 | $150,000 | 0 | $0 | 6,250 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | MELA | 67,567 | $49,999 | 0 | $0 | 0 | $0 |
| 2013 | MELA | 65,000 | $48,935 | 0 | $0 | 0 | $0 |
| 2011 | MELA | 21,457 | $85,184 | 0 | $0 | 0 | $0 |
1. Wafergen Bio-systems, Inc. (WGBS)
2. Strata Skin Sciences, Inc. (MELA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-09-16 | WGBS | Option Ex | 1,250 | .00 | 0 |
| 2011-06-16 | WGBS | Option Ex | 1,250 | .00 | 0 |
| 2011-02-28 | WGBS | Buy | 59,391 | 1.00 | 59,391 |
| 2010-09-16 | WGBS | Option Ex | 5,000 | .00 | 0 |
| 2010-12-16 | WGBS | Option Ex | 1,250 | .00 | 0 |
| 2010-07-07 | WGBS | Buy | 125,000 | 1.20 | 150,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-02-05 | MELA | Buy | 67,567 | .74 | 49,999 |
| 2013-06-27 | MELA | Buy | 15,000 | .87 | 13,035 |
| 2013-06-24 | MELA | Buy | 50,000 | .72 | 35,900 |
| 2011-12-21 | MELA | Buy | 21,457 | 3.97 | 85,184 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coradini Robert (Director of Strata Skin Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.